Etiological Factors Causing Lower Respiratory Tract Infections Isolated from Hospitalized Patients
Lower respiratory tract infections (LRTI) account for 20–30 % of all hospital-acquired contagions. They are characterized by high mortality of hospitalized patients. The most serious form of LRTI is pneumonia, and the most common etiological factors in such cases are bacteria. The article gives the analysis of bacterial flora samples obtained from lower respiratory tract of hospitalized patients. In vitro susceptibility of pathogens to selected antibiotics has also been assessed. We carried out a retrospective analysis of 1,171 bacterial strains isolated from 1,171 patients treated in clinics of the Military Institute of Medicine in Warsaw, Poland. In most cases the samples were collected from an endotracheal or tracheostomic tube (71.5 %) and from bronchoalveolar lavage (21.7 %). The most commonly isolated pathogens included Acinetobacter baumannii (35.8 %), Staphylococcus aureus (27.6 %), Klebsiella pneumoniae (19.4 %), and Pseudomonas aeruginosa (16.2 %). Multidrug-resistant gram-negative bacteria exhibited 100 % susceptibility to colistin only. Klebsiella pneumoniae ESBL+ and Acinetobacter baumannii were most susceptible to carbapenems, while Pseudomonas aeruginosa strains to ceftazidime. Methicillin-resistant Staphylococcus aureus were 100 % susceptible to vancomycin, linezolid, and tigecycline. In conclusion, identifying the etiological factors causing infections of the lower respiratory tract and determining their drug-susceptibility is of key importance in empirical treatment.
KeywordsAntibiotics Hospital treatment Respiratory infection Susceptibility
We thank Dr. Andrzej Truszczyński from the Clinic of Anesthesiology and Intensive Care of the Military Institute of Medicine in Warsaw for his support during collecting the data. This work was supported by the Polish Ministry of Science and High Education (Theme no. 222/213, Military Institute of Medicine in Warsaw, Poland).
Conflicts of Interest
The authors declare no conflict of interest in relation to this article.
- Clinical and Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement M100-S18. CLSI, Wayne. Accessed 12 Aug 2011Google Scholar
- European Committee on Antimicrobial Susceptibility Testing (2011) EUCAST criteria. Available from: http://www.eucast.org. Accessed 12 Aug 2011
- Hryniewicz W, Ozorowski T (2011) Hospital list of antibiotics. National Medicines Institute, Warszawa, pp 19–22Google Scholar
- Hryniewicz W, Grzesiowski P, Kozielski J, Kuś J, Meszaros J, Ozorowski T, Pirożyński M, Płusa T, Radzikowski A (2008) Recommendations for diagnostics and treatment of respiratory tract infections. National Program of Antibiotic Protection, Warszawa, pp 5–7Google Scholar
- Intensive Care Antimicrobial Resistance Epidemiology (1996) Surveillance report, data summary from January 1996 through December 1997: a report from the National Nosocomial Infections Surveillance System. Am J Infect Control 27(3):279–287Google Scholar
- Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak M, Talan DA, Chambers HF (2011) Clinical practice guidelines by the Infectious Diseases Society of America for treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52(3):18–55CrossRefGoogle Scholar
- National Reference Center for Antimicrobial Susceptibility (2013) National Medicines Institute. National Laboratory of Medicinal Products, Medical Devices and Biocidal Products Control, Warsaw. Available from: http://www.il.waw.pl/eng/ZE.html. Accessed 10 Aug 2013
- Płusa T (2013) Severe respiratory tract infections and rational antibiotic therapy. Int Rev Allergol Clin Immunol 1:7–11Google Scholar
- Rello J, Ulldemolins M, Lisboa T, Koulenti D, Manez R, Martin-Loeches I, De Waele JJ, Putensen C, Guven M, Deja M, Diaz E (2011) Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. Eur Respir J 37(6):1332–1339PubMedCrossRefGoogle Scholar
- Rybicki Z (2012) Antibiotherapy in the treatment of hospital acquired infections. Makmed, Lublin, pp 222–224Google Scholar